Chronic inflammatory bowel diseases: Predicting the success of biologicals
An international team led by researchers from the Cluster of Excellence PMI has found biomarkers that indicate at the beginning of anti-TNF alpha therapy whether it will be effective.
Nov 14, 2022
0
11